Glycosyltransformation of ginsenoside Rh2 into two novel ginsenosides using recombinant glycosyltransferase from Lactobacillus rhamnosus and its in vitro applications
Dan-Dan Wang,Yeon-Ju Kim,Nam In Baek,Ramya Mathiyalagan,Chao Wang,Yan Jin,Xing Yue Xu,Deok-Chun Yang
DOI: https://doi.org/10.1016/j.jgr.2019.11.004
IF: 5.735
2021-01-01
Journal of Ginseng Research
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Ginsenoside Rh2 has been exhibited groups of biological applications, such as anti-cancer, anti-diabetes, anti-inflammatory, and anti-obesity. Glycosyltransferases (GTs) are ubiquitous enzymes present in nature and are widely utilized for the synthesis of oligosaccharides, polysaccharides, glycoconjugates and novel derivatives. We aimed to synthesize new ginsenosides from Rh2 using recombinant glycosyltransferase enzyme and investigate its cytotoxicity with diverse cell lines.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>We have utilized a GT gene with 1,224 bp gene sequence cloned from <em>Lactobacillus rhamnosus</em> (LRGT)<em>,</em> and then expressed in <em>Escherichia coli</em> BL21 (DE3). The recombinant GT protein was purified and demonstrated to transform Rh2 to two novel ginsenosides, and they were characterized by NMR techniques and evaluated by MTT assay.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Two novel ginsenosides with an additional glucopyranosyl (6→1) and two additional glucopyranosyl (6→1) linked with C-3 position of substrate Rh2 were synthesized, respectively. Cell viability assay in lung cancer (A549) cell line showed that glucosyl-ginsenoside Rh2 inhibited cell viability more potent than ginsenoside Rg3 and Rh2 at a concentration of 10 μM. Furthermore, glucosyl-ginsenoside Rh2 did not exhibit any cytotoxic effect in murine macrophage cells (RAW264.7), mouse embryo fibroblasts cells (3T3-L1), and skin cells (B16BL6) at a concentration of 10 μM compared with ginsenoside Rh2 and Rg3.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>This is the first report on the synthesis of two novel ginsenosides, namely glucosyl-ginsenoside Rh2 and diglucosyl-ginsenoside Rh2 from Rh2 by utilizing recombinant glycosyltransferase isolated from <em>L. rhamnosus</em>. Moreover, diglucosyl-ginsenoside Rh2 might be a new candidate for treatment of inflammation, obesity and skin whiting, and especially for anticancer.</p>
chemistry, medicinal,integrative & complementary medicine